| For: | Kokudeva M, Vichev M, Naseva E, Miteva DG, Velikova T. Artificial intelligence as a tool in drug discovery and development. World J Exp Med 2024; 14(3): 96042 [PMID: 39312699 DOI: 10.5493/wjem.v14.i3.96042] |
|---|---|
| URL: | https://www.wjgnet.com/2220-315X/full/v14/i3/96042.htm |
| Number | Citing Articles |
| 1 |
Bakr Ahmed Taha, Ali J. Addie, Luai Farhan Zghair Kolie, Saba Talib Wahhab, Sinan Adnan Abdulateef, Adawiya J. Haider, Khalid Ibnaouf, Norhana Arsad. Advancements in nanophotonics and smart nanomaterials integrated with artificial intelligence-driven gene editing: A paradigm shift in cancer diagnosis and therapeutic. Chinese Chemical Letters 2026; 37(4) doi: 10.1016/j.cclet.2025.111955
|
| 2 |
Razvan Onciul, Catalina-Ioana Tataru, Adrian Vasile Dumitru, Carla Crivoi, Matei Serban, Razvan-Adrian Covache-Busuioc, Mugurel Petrinel Radoi, Corneliu Toader. Artificial Intelligence and Neuroscience: Transformative Synergies in Brain Research and Clinical Applications. Journal of Clinical Medicine 2025; 14(2) doi: 10.3390/jcm14020550
|
| 3 |
Elisa Avolio, Barbara Bassani, Marzia Campanile, Khaled AK. Mohammed, Paola Muti, Antonino Bruno, Gaia Spinetti, Paolo Madeddu. Shared molecular, cellular, and environmental hallmarks in cardiovascular disease and cancer: Any place for drug repurposing?. Pharmacological Reviews 2025; 77(2) doi: 10.1016/j.pharmr.2024.100033
|
| 4 |
Artificial intelligence in drug discovery and development: transforming challenges into opportunities. Discover Pharmaceutical Sciences 2025; 1(1) doi: 10.1007/s44395-025-00007-3
|
| 5 |
M. Dimitrova, R. Trifonova, G. Stavrakov, I. Doytchinova, G. Petrova. Artificial Intelligence-Based Approaches for Improving Regulatory Market Access – A Case Study with A Scoping Review for Repurposing of Medicinal Products in the Pandemic. Acta Medica Bulgarica 2026; 53(s1) doi: 10.2478/amb-2026-0026
|
| 6 |
Vikas Sharma, Kamlesh Kumar Gautam, Tarun Kumar Vashishth, Ravi Kant, Krishana Kumar Sharma, Shahanawaj Ahamad. AI Foundations, Technologies, and Future of Healthcare Systems. Advances in Computational Intelligence and Robotics 2026; doi: 10.4018/979-8-2600-0981-9.ch005
|
| 7 |
Sunil Sankathala, Susanta Das. AI-Driven Pharmacology, Toxicology, and Drug Safety. Advances in Computational Intelligence and Robotics 2026; doi: 10.4018/979-8-3373-8562-4.ch003
|
| 8 |
Helen Smith, Jonathan Ives. Professional ethical guidance for AI use (PEG-AI) in healthcare: a rapid scoping review. AI and Ethics 2026; 6(6) doi: 10.1007/s43681-026-01443-2
|
| 9 |
Aliasgar Baldiwala, Azim M Baldiwala, Manan Patel, Pritkumar Amrutiya, Gopal Natesan, Udit Chaube. Artificial intelligence for next-generation anxiolytic drug discovery: current trends, challenges, and future perspectives. Chemical Papers 2026; 80(4) doi: 10.1007/s11696-025-04598-0
|
| 10 |
Alaa Marwan-Abu-Taha. Elevating Research and Careers in the Development of Safer Drugs through Artificial Intelligence. Chemical Research in Toxicology 2025; 38(3) doi: 10.1021/acs.chemrestox.4c00423
|
| 11 |
Amauri Duarte da Silva, Walter Filgueira de Azevedo. Docking Screens for Drug Discovery. Methods in Molecular Biology 2026; 2984 doi: 10.1007/978-1-0716-4949-7_5
|
| 12 |
|
| 13 |
Rubhashri Gurunathan, Rajaram Abhirami, Muthuraja Arun Pravin, Sanjeev Kumar Singh. The AI Frontier in Molecular Modelling and Drug Designing. 2027; doi: 10.1016/B978-0-443-40338-5.00012-3
|
| 14 |
Ádám Pannonhalmi, Bence Sipos, Róbert Imre Kurucz, Gábor Katona, Lajos Kemény, Ildikó Csóka. Advancing Regulatory Oversight of Medical Device Trials to Align with Clinical Drug Standards in the European Union. Pharmaceuticals 2025; 18(6) doi: 10.3390/ph18060876
|
| 15 |
Bruno F. E. Matarèse. Quantum and Artificial Intelligence in Drugs and Pharmaceutics. BioChem 2026; 6(1) doi: 10.3390/biochem6010002
|
| 16 |
Sanjit Kr. Roy, Kazi Asraf Ali, Subhankar Saha, Bichitra Biswas. Revolutionizing Drug Development. 2026; doi: 10.1016/B978-0-443-34059-8.00014-2
|
| 17 |
Ibrahim A. Alradwan, Sarah A. Allabban, Aram S. Aleissa, Norah M. Alqahtani, Hamzah A. Alghamdi, Nojoud Al Fayez, Manal A. Alshabibi, Essam A. Tawfik, Fahad A. Almughem, Abdullah A. Alshehri. Pulmonary Drug Delivery in the Era of Nanomedicine: From Biological Barriers to Artificial Intelligence-Driven Optimization. Pharmaceuticals 2026; 19(7) doi: 10.3390/ph19071095
|
| 18 |
Shahrzad Latifi. Targeting Brain Networks for Recovery: Multimodal Innovations in Poststroke Therapy. Stroke 2026; 57(5) doi: 10.1161/STROKEAHA.125.053926
|
| 19 |
Sara Laianny Ferreira Cunha, Maria de Jesus Costa das Neves , Franciélio Alves Silva , Raynara Beatriz Magalhães Morais , Luiza Sousa Oliveira , Beatriz Lisboa Pinto , Letícia Alves Santos , Kalynna Beatriz Araujo Diniz , Kamila Cristhine Bede Camilo , Karen Silva de Almeida . AVANÇOS NO DIAGNÓSTICO E TRATAMENTO DE DOENÇAS NEUROLÓGICAS: NOVAS ESTRATÉGIAS TERAPÊUTICAS E DESAFIOS CLÍNICOS NO CONTEXTO ATUAL. Cognitus Interdisciplinary Journal 2025; 2(2) doi: 10.71248/xmdf9133
|
| 20 |
Ioannis G. Papadimitriou, George Mastorakis, Ioannis V. Aspirtakis, Konstantinos Vassakis, Athina Bourdena, Constandinos X. Mavromoustakis, Evangelos Markakis. Intelligent Transformative Technologies. Signals and Communication Technology 2026; doi: 10.1007/978-3-032-02705-4_14
|
| 21 |
Mohammad Javad Mehran, Sara Mohammadzadeh, Mansoor Bolideei, Rambod Barzigar, Khawaja Husnain Haider, Nasir Jadgal, Yadollah Bahrami. Artificial Intelligence in Drug Discovery: Integrative Advances From Data to Therapeutic Innovation. Drug Development Research 2026; 87(2) doi: 10.1002/ddr.70229
|
| 22 |
Somayah J. Jarallah, Fahad A. Almughem, Nada K. Alhumaid, Nojoud AL Fayez, Ibrahim Alradwan, Khulud A. Alsulami, Essam A. Tawfik, Abdullah A. Alshehri. Artificial intelligence revolution in drug discovery: A paradigm shift in pharmaceutical innovation. International Journal of Pharmaceutics 2025; 680 doi: 10.1016/j.ijpharm.2025.125789
|
| 23 |
K. Daqrouq, S. Alghamedi, S. Alwaseli, A. F. Alkhateeb, Sami Alghamdi, M. N. Ajour, A. S. Balamash, A. Milyani, K. Alharbi, A. M. Rushdi, Giovanni Angiulli. Impact of the Utilization of Artificial Intelligence in the Development of Electrical Engineering. Journal of Engineering 2025; 2025(1) doi: 10.1155/je/1390935
|
| 24 |
Surendra Prakash Gupta, Ankur Bhardwaj. AI and Ecological Change for Sustainable Development. Advances in Computational Intelligence and Robotics 2025; doi: 10.4018/979-8-3373-0680-3.ch014
|
| 25 |
Vinay Kumar, Kunal Roy. Embracing the changes and challenges with modern early drug discovery. Expert Opinion on Drug Discovery 2025; 20(4) doi: 10.1080/17460441.2025.2481259
|
| 26 |
Abdullah A. Alshehri, Alhassan H. Aodah, Ibrahim A. Alradwan, Meshal K. Alnefaie, Majed S. Nassar, Ibtihal S. Alduhaymi, Ahmad M. Aldossary, Nojoud Al Fayez, Essam A. Tawfik, Fahad A. Almughem. Bacteriophages as Therapeutic Agents for Pulmonary Infections: From Biological Principles to Clinical Applications. Pharmaceutics 2026; 18(3) doi: 10.3390/pharmaceutics18030387
|
| 27 |
Vanshika Kumar, Nida Akhter, Lucky Krishnia, Manoj Kumar Kashyap. Artificial Intelligence for Enhanced Diagnosis in Oncology. 2026; doi: 10.1016/B978-0-443-45004-4.00009-8
|
| 28 |
AI-driven approaches in therapeutic interventions: Transforming RNA-seq analysis into biomarker discovery and drug development. Drug Discovery Today 2025; 30(7) doi: 10.1016/j.drudis.2025.104391
|
| 29 |
Mikhail Parshenkov, Sergey Zyryanov, Galina Rodionova, Anna Dyakonova, Petr Shegay, Andrei Kaprin, Grigory Demyashkin. Personalizing Antidepressant Therapy: Integrating Pharmacogenomics, Therapeutic Drug Monitoring, and Digital Tools for Improved Depression Outcomes. Journal of Personalized Medicine 2025; 15(12) doi: 10.3390/jpm15120616
|
| 30 |
Abhishek Kumar, Pranesh Kumar, Namrata Singh, Prashant Kumar Singh, Anshi Singh. Artificial intelligence across the drug discovery pipeline: From data integration to precision therapeutics. The Journal of Precision Medicine: Health and Disease 2026; 8 doi: 10.1016/j.premed.2026.100061
|
| 31 |
Kathirvel Sekar, Kaviyarasi Renu, Sathishkumar Vinayagam, Devianjana Rajendran, Kamaraj Sattu. In Silico Development of PABA-substituted Pyrimidine Derivatives Targeting Mutant p53 for Precision Therapy in Oral Squamous Cell Carcinoma. Journal of Advanced Oral Research 2025; 16(2) doi: 10.1177/23202068251330106
|
| 32 |
Sonopant Joshi, Husain Nadaf, Mangesh Jabade, Shital Pimpalekar. Artificial Intelligence in Oncology. 2025; doi: 10.1007/978-3-031-94302-7_42
|
| 33 |
Pankaj Garg, Gargi Singhal, Prakash Kulkarni, David Horne, Ravi Salgia, Sharad S. Singhal. Artificial Intelligence–Driven Computational Approaches in the Development of Anticancer Drugs. Cancers 2024; 16(22) doi: 10.3390/cancers16223884
|
| 34 |
Jin Gao, Xiaohui Liu. Mechanistic Study of Multi-Component and Multi-Target Effects of Traditional Chinese Medicine Formulae Based on Artificial Intelligence and Network Pharmacology. Proceedings of the 2026 6th International Conference on Applied Mathematics, Modelling and Intelligent Computing 2026; doi: 10.1145/3817124.3817321
|
| 35 |
Krishna Chandra Panda, Bera Venkata Varaha Ravi Kumar, Jammula Sruti, Harjakhya Kishore Sundeep Kumar, Suman Acharyya. A Comprehensive Review on Modelling Techniques in Drug Research and Development. Applied Drug Research, Clinical Trials and Regulatory Affairs 2026; 12 doi: 10.2174/0126673371410546251201054257
|
| 36 |
Raja Ahmed, Suraiya Akhtar, Ankur Das, Khaleda Begum, Abhijit Sarma, Amartya Chakraborty, Tanisha Neog, Sofia Banu. Revolutionizing Drug Development. 2026; doi: 10.1016/B978-0-443-34059-8.00010-5
|
| 37 |
Sanjay Kumar, Manish Kumar Gupta. The AI Frontier in Molecular Modelling and Drug Designing. 2027; doi: 10.1016/B978-0-443-40338-5.00010-X
|
| 38 |
Attila A. Seyhan, Claudio Carini. Artificial Intelligence in drug discovery and development: current landscape, challenges, and future perspectives. Critical Reviews in Oncology/Hematology 2026; 226 doi: 10.1016/j.critrevonc.2026.105461
|
| 39 |
Da Li, Sanbao Shi, Zhiyu Yu, Peng Xu, Cheng Zhang. AI accelerate the identification of druggable targets by 3D structures of proteins and compounds. npj Precision Oncology 2026; 10(1) doi: 10.1038/s41698-026-01310-7
|
| 40 |
Lalmohan Barman, Suman Hazra, Dhrubajyoti Majumdar, Sudipta Dalai. A Comprehensive Review on Cu(II) Complexes With Pyrazine or Pyrazine Derivatives: Synthesis, Characterization, Crystal Engineering, Magnetic, and Biological Applications. ChemistrySelect 2026; 11(37) doi: 10.1002/slct.74689
|
| 41 |
Rebekah Clarke, Giuseppe Palazzo, Jiri Ruzicka, Salvatore Ferla, Marcella Bassetto. Computer-aided drug discovery: historical foundations, practical AI tools, and emerging ethical considerations. Frontiers in Pharmacology 2026; 17 doi: 10.3389/fphar.2026.1866562
|
| 42 |
Aayusree Ray, Shreya Dey, Debjeet Sur. Blueprint for Drug Repurposing Success: Foundational Concepts and Practical Framework. Drug Development Research 2026; 87(2) doi: 10.1002/ddr.70270
|
| 43 |
Hema Brindha Masanam, Siva Prasath Ramasamy, Sapthagirivasan Vivekanandhan, Ashwin Kumar Narasimhan. Precision Medicine Demanding Artificial Intelligence for Nanodrug Delivery Enhancing Cancer Treatment. Nano LIFE 2026; 16(04) doi: 10.1142/S1793984425300079
|
| 44 |
Bhavika Baweja, Chainsee Saini, Prerna Vats, Rashi Soni, Kritika Jangir, Prachi Patidar, Ashok Kumar, Rajeev Nema. BUB signaling in cancer and molecular insights into targeted therapies. Communications Biology 2026; 9(1) doi: 10.1038/s42003-026-10976-5
|